Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriers

Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriers - Study on RRSO for BRCA1/2 mutation carriers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005292

Enrollment

200

Registered

2011-04-01

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. BRCA1/2 mutation carrier 2. the subjects understand and consent to problesms on pregnancy, childbirth and so on.

Exclusion criteria

Exclusion criteria: 1.She desires having babies. 2.The case in which IRB doesn't approve to perform PBSO.

Design outcomes

Primary

Measure	Time frame
safety and outcome of risk reducing bilateral salpingo-oophorectomy	—

Secondary

Measure	Time frame
actual medical fee for RRSO pathological findings of resested specimen for PBSO satisfaction with PBSO	—

Countries

Japan

Contacts

Public ContactHidetaka Nomura

Cancer Institute Hospital Gynecology

hidetaka.nomura@jfcr.or.jp03-3520-0111

Outcome results